A noninvasive measure of heart and blood vessel function called the TAPSE/sPAP ratio can help doctors objectively assess the severity of day-to-day symptoms in people with pulmonary arterial hypertension (PAH), according to a new study. Researchers found that lower ratio values closely mirror greater physical limitations in patients, providing…
Discussion
A measurement taken by heart MRI was linked to several invasive measures used to assess pulmonary hypertension (PH), a new study shows. The measurement, known as T2RV/LV, “represents a highly promising non-invasive biomarker for risk stratification, disease monitoring, and assessment of treatment response in PH,” the researchers wrote. They…
Discussion
Pulmonary hypertension (PH) has changed what I consider an accomplishment — and maybe that isn’t such a bad thing. Living with PH has taught me that progress does not have to be dramatic to be worth celebrating. Walking a little farther, recovering a little faster, adjusting to a…
Discussion
Two blood-based biomarkers — GDF-15 and NT-proBNP — most accurately distinguished adults with pulmonary hypertension (PH) from healthy individuals in a study that compared five biomarkers. The retrospective study, conducted at Beijing Anzhen Hospital in China, evaluated traditional and newer biomarkers across the four main clinical subtypes of…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
